Back to today’s briefing

Story perspectives

Study Reveals Ulipristal Acetate's 97% Success in Early Pregnancy Termination

1/25/2025

50 9

Summary

Story summary

A groundbreaking study in NEJM Evidence reveals that increasing the dose of ulipristal acetate, found in the emergency contraceptive Ella, could terminate early pregnancies with a remarkable 97% success rate. This revelation adds a new layer of complexity to the heated political debates over reproductive health in the U.S., especially in the wake of Roe v. Wade's reversal.

History

Historical Context

A recent study indicates that increasing the dosage of ulipristal acetate, an emergency contraceptive, could terminate early pregnancies with a 97% success rate. This finding intensifies the ongoing debates over reproductive rights in the U.S., particularly following the Supreme Court's 2022 decision to overturn Roe v. Wade, which previously protected abortion rights and ignited a national conversation on reproductive health access.

1 of 2

Story summary

A groundbreaking study in NEJM Evidence reveals that increasing the dose of ulipristal acetate, found in the emergency contraceptive Ella, could terminate early pregnancies with a remarkable 97% success rate. This revelation adds a new layer of complexity to the heated political debates over reproductive health in the U.S., especially in the wake of Roe v. Wade's reversal.

1 / 2